Perspective on the FDA’s New Focus

Oversimplifying a deeply systemic issue

In the recent JAMA Viewpoint by Makary & Prasad, the FDA’s renewed emphasis on food additives and ultraprocessed foods as drivers of chronic disease is a welcome public health lens—but it risks oversimplifying a deeply systemic issue.

Yes, chemically manipulated diets merit scrutiny. But attributing the crisis of chronic disease primarily to food distracts from the structural deficiencies that underlie poor health outcomes in the U.S.—namely, the absence of universal healthcare and widespread barriers to accessing timely, affordable care and medications.

While 40% of U.S. children have chronic conditions, blaming “bad food” without addressing our fragmented, inequitable healthcare delivery model misdirects the conversation. Millions remain uninsured or underinsured, leading to preventable morbidity and worsening disparities.

We must be vigilant against narratives that shift accountability from institutional neglect to individual consumption. A holistic approach to public health requires not just cleaner food—but just and accessible healthcare.

#PublicHealth #HealthcareEquity #FDA #ChronicDisease #SocialDeterminantsOfHealth #PolicyMatters

https://jamanetwork.com/journals/jama/fullarticle/2835314